Condition
Stage IIIb Non-small Cell Lung Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Stage IIIb Non-small Cell Lung Cancer clinical trials that are recruiting, at sites in 2 countries (most in China (1), Vietnam (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Neoadjuvant SBRT then sintilimab with chemotherapy for N3-positive locally advanced NSCLC
This approach tests whether focused radiation to the primary lung tumor followed by two cycles of sintilimab plus platinum-based chemotherapy before surgery can shrink N3-positive locally advanced non-small cell lung cancer and enable curative surgery.
-
Analyzing tumor DNA to predict response to cancer treatment in lung cancer patients
This study is testing if measuring tumor DNA in the blood can help predict how well lung cancer patients respond to a specific treatment called Tyrosine Kinase Inhibitors.
Related topics
Quick answers
How many Stage IIIb Non-small Cell Lung Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Vietnam (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.